Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib)
Amgen announced on the 27th August, 2018 the submission of a supplemental New Drug Application (sNDA) to the U.S. Food
A forum for researchers, students and applicants in the field of cyclodextrin technology
Amgen announced on the 27th August, 2018 the submission of a supplemental New Drug Application (sNDA) to the U.S. Food
Recently, a new patent application became accessible to the public, WO2018146698 (A1), filed by Biophore India, a DMF holder for the
The biggest pharma exhibition in the world, CPHI Worldwide will be organized 9-11th October in Madrid. By joining (which is
For those, interested in building relationships with industrial partners as well as broadening their knowledge in state-of-the-art academic research, AAPS